Selected article for: "absolute number and long term"
Author: Rha, Min-Seok; Shin, Eui-Cheol
Title: Activation or exhaustion of CD8(+) T cells in patients with COVID-19
  • Cord-id: o94p7ita
  • Document date: 2021_8_19
    • ID: o94p7ita
    Snippet: In addition to CD4(+) T cells and neutralizing antibodies, CD8(+) T cells contribute to protective immune responses against SARS-CoV-2 in patients with coronavirus disease 2019 (COVID-19), an ongoing pandemic disease. In patients with COVID-19, CD8(+) T cells exhibiting activated phenotypes are commonly observed, although the absolute number of CD8(+) T cells is decreased. In addition, several studies have reported an upregulation of inhibitory immune checkpoint receptors, such as PD-1, and the
    Document: In addition to CD4(+) T cells and neutralizing antibodies, CD8(+) T cells contribute to protective immune responses against SARS-CoV-2 in patients with coronavirus disease 2019 (COVID-19), an ongoing pandemic disease. In patients with COVID-19, CD8(+) T cells exhibiting activated phenotypes are commonly observed, although the absolute number of CD8(+) T cells is decreased. In addition, several studies have reported an upregulation of inhibitory immune checkpoint receptors, such as PD-1, and the expression of exhaustion-associated gene signatures in CD8(+) T cells from patients with COVID-19. However, whether CD8(+) T cells are truly exhausted during COVID-19 has been a controversial issue. In the present review, we summarize the current understanding of CD8(+) T-cell exhaustion and describe the available knowledge on the phenotypes and functions of CD8(+) T cells in the context of activation and exhaustion. We also summarize recent reports regarding phenotypical and functional analyses of SARS-CoV-2-specific CD8(+) T cells and discuss long-term SARS-CoV-2-specific CD8(+) T-cell memory.

    Search related documents:
    Co phrase search for related documents
    • acid oxidation and acute infection: 1, 2
    • activate cell and acute infection: 1, 2, 3, 4
    • activate cell and acute respiratory distress syndrome: 1
    • activate cell and acute respiratory virus: 1, 2, 3
    • activation dysfunction and acute infection: 1, 2, 3, 4, 5, 6, 7
    • activation dysfunction and acute patient: 1, 2, 3
    • activation dysfunction and acute respiratory distress syndrome: 1, 2, 3, 4
    • activation dysfunction and acute respiratory virus: 1
    • activation induce and acute infection: 1, 2, 3, 4, 5
    • activation induce and acute phase: 1
    • activation induce and acute respiratory distress syndrome: 1, 2, 3
    • activation induce and acute respiratory virus: 1
    • activation marker and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • activation marker and acute phase: 1, 2, 3, 4
    • activation marker and acute respiratory distress syndrome: 1, 2, 3
    • activation phenotype and acute infection: 1, 2, 3, 4, 5
    • activation phenotype and acute respiratory distress syndrome: 1, 2, 3, 4, 5